Immuron Limited (IMRN)

Revenue by Product

Financials in millions AUD. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011	Jun 30, 2010	Jun 30, 2009	Jun 30, 2008	Jun 30, 2007	Jun 30, 2006	Jun 30, 2005
Hyper-immune Products	4.90M
Hyper-immune Products Growth	171.67%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011	Jun 30, 2010	Jun 30, 2009	Jun 30, 2008	Jun 30, 2007	Jun 30, 2006	Jun 30, 2005
Australia	3.75M
Australia Growth	222.77%
United States	1.08M
United States Growth	67.33%
Canada	80.89K
Canada Growth	6635.05%